Page 81 - Read Online

a b
Figure 8: Relative ex-microRNAs expression analysis in CSF, MB cell lines: (a) TaqMan qRT-PCR analysis for miR-1298 compared to 5 controls: Ctrl 1 CSF from
leukemia patient, Ctrl 2 CSF from glioblastoma patient, Ctrl 3-5 CSF from 3 ependymoma patients (n = 3; ± SD); (b) TaqMan qRT-PCR analysis for miR-1290,
miR-125a in serial dilution of D341 CM (n = 3; ± SD). CM: Culture-medium; MB: Medulloblastoma; CSF: Cerebral spinal fl uid; qRT-PCR: Quantitative reverse
transcription polymerase chain reaction; SD: standard deviation

Acknowledgments levels of tumour-associated microRNAs in serum of
patients with diffuse large B-cell lymphoma. Br J Haematol
This project was supported by the Swiss Research Foundation 2008;141:672-5.
Child and Cancer and by “Krebsliga Zürich”. 1 2. Tanaka M, Oikawa K, Takanashi M, Kudo M, Ohyashiki J,
Ohyashiki K, Kuroda M. Down-regulation of miR-92 in
R eferences human plasma is a novel marker for acute leukemia patients.
1. Gurney JG, Smith MA, Bunin GR. C NS and miscellaneous PLoS One 2009;4:e5532.
intracranial and intraspinal neoplasms. In: Ries LA, 1 3. Huang Z, Huang D, Ni S, Peng Z, Sheng W, Du X. Plasma
Smith MA, Gurney JG, Linet M, Tamra T, Young JL, microRNAs are promising novel biomarkers for early
Bunin GR, editors. Cancer Incidence and Survival Among detection of colorectal cancer. Int J Cancer 2010;127:118-26.
Children and Adolescents: United States SEER Program 1 4. Heneghan HM, Miller N, Lowery AJ, Sweeney KJ, Newell J,
1975-1995. Bethesda: National Institutes of Health; 1999. Kerin MJ. Circulating microRNAs as novel minimally invasive
p. 51-63. biomarkers for breast cancer. Ann Surg 2010;251:499-505.
2 . Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Burger PC, 1 5. Brase JC, Johannes M, Schlomm T, Fälth M, Haese A,
Jouvet A, Scheithauer BW, Kleihues P. The 2007 WHO Steuber T, Beissbarth T, Kuner R, Sültmann H. Circulating
Classifi cation of Tumours of the Central Nervous System. miRNAs are correlated with tumor progression in prostate
Acta Neuropathol 2007;114:97-109. cancer. Int J Cancer 2011;128:608-16.
3 . Tran N, McLean T, Zhang X, Zhao CJ, Thomson JM, 16. Resnick KE, Alder H, Hagan JP, Richardson DL, Croce CM,
O’Brien C, Rose B. MicroRNA expression profi les in head Cohn DE. The detection of differentially expressed
and neck cancer cell lines. Biochem Biophys Res Commun microRNAs from the serum of ovarian cancer patients using a
2007;358:12-7. novel real-time PCR platform. Gynecol Oncol 2009;112:55-9.
4 . Calin GA, Croce CM. Chronic lymphocytic leukemia: 17. Wang J, Chen J, Chang P, LeBlanc A, Li D, Abbruzzesse JL,
interplay between noncoding RNAs and protein-coding genes. Frazier ML, Killary AM, Sen S. MicroRNAs in plasma of
Blood 2009;114:4761-70. pancreatic ductal adenocarcinoma patients as novel blood-based
5 . He H, Jazdzewski K, Li W, Liyanarachchi S, Nagy R, biomarkers of disease. Cancer Prev Res (Phila) 2009;2:807-13.
Volinia S, Calin GA, Liu CG, Franssila K, Suster S, Kloos RT, 18. Tsujiura M, Ichikawa D, Komatsu S, Shiozaki A, Takeshita H,
Croce CM, de la Chapelle A. The role of microRNA genes Kosuga T, Konishi H, Morimura R, Deguchi K, Fujiwara H,
in papillary thyroid carcinoma. Proc Natl Acad Sci U S A Okamoto K, Otsuji E. Circulating microRNAs in plasma of
2005;102:19075-80. patients with gastric cancers. Br J Cancer 2010;102:1174-9.
6 . Si ML, Zhu S, Wu H, Lu Z, Wu F, Mo YY. MiR-21-mediated 19. Hu Z, Chen X, Zhao Y, Tian T, Jin G, Shu Y, Chen Y, Xu L,
tumor growth. Oncogene 2007;26:2799-803. Zen K, Zhang C, Shen H. Serum microRNA signatures
7 . Alsidawi S, Malek E, Driscoll JJ. MicroRNAs in brain identifi ed in a genome-wide serum microRNA expression
metastases: potential role as diagnostics and therapeutics. Int J profi ling predict survival of non-small-cell lung cancer. J Clin
Mol Sci 2014;15:10508-26. Oncol 2010;28:1721-6.
8 . Kosaka N, Iguchi H, Ochiya T. Circulating microRNA in body 20. Baraniskin A, Kuhnhenn J, Schlegel U, Maghnouj A,
fl uid: a new potential biomarker for cancer diagnosis and Zöllner H, Schmiegel W, Hahn S, Schroers R. Identifi cation
prognosis. Cancer Sci 2010;101:2087-92. of microRNAs in the cerebrospinal fl uid as biomarker for the
9 . Chen X, Liang H, Zhang J, Zen K, Zhang CY. Secreted diagnosis of glioma. Neuro Oncol 2012;14:29-33.
microRNAs: a new form of intercellular communication. 21. Akers JC, Ramakrishnan V, Kim R, Skog J, Nakano I,
Trends Cell Biol 2012;22:125-32. Pingle S, Kalinina J, Hua W, Kesari S, Mao Y, Breakefi eld XO,
1 0. Liang H, Gong F, Zhang S, Zhang CY, Zen K, Chen X. The Hochberg FH, Van Meir EG, Carter BS, Chen CC. MiR-21 in
origin, function, and diagnostic potential of extracellular the extracellular vesicles (EVs) of cerebrospinal fl uid (CSF): a
microRNAs in human body fl uids. Wiley Interdiscip Rev RNA platform for glioblastoma biomarker development. PLoS One
2014;5:285-300. 2013;8:e78115.
1 1. Lawrie CH, Gal S, Dunlop HM, Pushkaran B, Liggins AP, 22. Teplyuk NM, Mollenhauer B, Gabriely G, Giese A, Kim E,
Pulford K, Banham AH, Pezzella F, Boultwood J, Smolsky M, Kim RY, Saria MG, Pastorino S, Kesari S,
Wainscoat JS, Hatton CS, Harris AL. Detection of elevated Krichevsky AM. MicroRNAs in cerebrospinal fl uid identify
74 Journal of Cancer Metastasis and Treatment ¦ Volume 1 ¦ Issue 2 ¦ July 15, 2015 ¦